Non-steroidal Anti-inflammatory Drugs Market Overview
The Non-steroidal Anti-inflammatory Drugs Market was valued at USD 27.03 Billion in 2025 and is projected to reach USD 41.75 Billion by 2032, growing at a CAGR of 6.4% during 2026–2032, with North America holding the largest share.
Primary Drivers
- Global rise in chronic pain prevalence driving demand for anti-inflammatory and analgesic therapies
- Growing elderly population more susceptible to conditions requiring pain management, particularly arthritis
- Expanded demand for OTC NSAIDs and broader applications in headaches, migraines, toothaches, and menstrual pain
Primary Challenges
- Generic competition pressuring pricing across the NSAID category
- Regulatory compliance requirements adding cost and complexity to product approvals
- Safety concerns associated with long-term NSAID use affecting prescribing and consumption patterns
This report includes a dedicated chapter covering supply chain exposure, export controls, sanctions risk, and regulatory shifts affecting Non-steroidal Anti-inflammatory Drugs Market.
Non-steroidal Anti-inflammatory Drugs Market Strategic Outlook
Growth trajectory, 2026–2032
How this market is covered
Revenue split by type
Revenue by end use
Profshare Market Research launches an in-detailed study of segments, market drivers, constraints, regional analysis, trends and forecast on Non-steroidal Anti-inflammatory Drugs Market. The study covers historical data analysis from 2020 and 2025 and market forecast for 2026 and 2032 based on revenue generated. Historical data provides trends & market patterns that forms base of the future growth. The Research report provides complete insight into growth and forecast of the Non-steroidal Anti-inflammatory Drugs Market.
Non-steroidal Anti-inflammatory Drugs Market Research study is prepared based on the data collected for product types, applications/end-user, company analysis & regional outlook. Primary product types are Oral, Injection. Product types analysis includes revenue generated for each product type, sales volume, growth rate & forecast. It is very important to understand the historical, current & future market for each product type as it forms base of the market valuation.
Application analysis segment enlightens the market revenue & volume for each application. A product/ service can be used across various industries& can have different types of end-user. This insight is a very important as it plays vital role to bridge-up the gap between current & future business strategies. Important applications are Osteoarthritis, Muscle Aches, Backaches.
Non-steroidal Anti-inflammatory Drugs Market Company analysis covers key players basic information, product category, Sales (Volume), Revenue (Million USD), and Gross Margin (%). The competitive landscape in the report offers detailed profiles of the key players in Non-steroidal Anti-inflammatory Drugs Market. The report also covers financial overview, market strategies, new product analysis and marketing trends. Precise Competitive analysis helps businesses to build new product strategies.
Based on geography, the Non-steroidal Anti-inflammatory Drugs Market can be segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, and the Rest of the World (ROW). Regional outlook helps to understand product revenue, volume & growth rate for the particular regions. Geographical market information enables users to carefully build a marketing strategy & gain more market share.
Non-steroidal Anti-inflammatory Drugs Market Research study has extensively worked on supply-demand analysis which has become important parameter in the industry. Supplier analysis helps to understand supply- demand scenario that certainly helps designed better manufacturing process. Analytical tools used while developing research studies include Porter's 5 Forces model, PESTEL analysis, SWOT analysis, market sizing, top-down & bottom-up research processes. Opportunities and challenges analysis enables to understand future growth rate of the market.
Global Non-steroidal Anti-inflammatory Drugs Market: Product Types
- Oral
- Injection
Global Non-steroidal Anti-inflammatory Drugs Market: Applications
- Osteoarthritis
- Muscle Aches
- Backaches
Global Non-steroidal Anti-inflammatory Drugs Market: Company Analysis
- Sanofi S.A.
- Novartis AG
- GlaxoSmithKline PLC
- Pfizer
- DOMESCO
Global Non-steroidal Anti-inflammatory Drugs Market: Regional Analysis
- North America
- U.S.A
- Canada
- Europe
- France
- Germany
- Spain
- UK
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South East Asia
- Latin America
- Brazil
- Middle East and Africa
Global Non-steroidal Anti-inflammatory Drugs Market Report delivers a comprehensive analysis of the following parameters :
- Market Forecast for 2023-29
- Market growth drivers
- Challenges and Opportunities
- Emerging and Current market trends
- Market player Capacity, Production, Revenue (Value)
- Supply (Production), Consumption, Export, Import analysis
- End-user/application Analysis
Pharmaceuticals Landscape
Report Coverage
| Parameter | Details |
|---|---|
| Base Year | 2025 |
| Historical Data | 2020 – 2025 |
| Forecast Period | 2026 – 2032 |
| Base Year Value | USD 27.03 Billion |
| Forecast Value | USD 41.75 Billion |
| CAGR | 6.4% |
| Regional Scope | North America · Europe · Asia-Pacific · Latin America · MEA · RoW |
Frequently Asked Questions
Non-steroidal Anti-inflammatory Drugs Market was valued at USD 27.03 Billion in 2025 and is estimated to reach USD 41.75 Billion by 2032.
Non-steroidal Anti-inflammatory Drugs Market is projected to grow at a CAGR of 6.4% during 2025–2032.
1. Global rise in chronic pain prevalence driving demand for anti-inflammatory and analgesic therapies 2. Growing elderly population more susceptible to conditions requiring pain management, particularly arthritis 3. Expanded demand for OTC NSAIDs and broader applications in headaches, migraines, toothaches, and menstrual pain
Yes. The report includes a dedicated section on geopolitical risk factors and their impact on supply chains, pricing, and regional demand dynamics.